Penumbra, Inc. (PEN)
287.14
-7.69
(-2.61%)
USD |
NYSE |
Dec 09, 16:00
287.18
+0.04
(+0.01%)
Pre-Market: 20:00
Penumbra EPS Diluted (Quarterly): 1.167 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Edwards Lifesciences Corp. | 0.5004 |
| Merit Medical Systems, Inc. | 0.4632 |
| ResMed, Inc. | 2.373 |
| Masimo Corp. | -1.859 |
| Insulet Corp. | 1.240 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 45.85M |
| Revenue (Quarterly) | 354.68M |
| Total Expenses (Quarterly) | 308.83M |
| Enterprise Value | 10.99B |
| Gross Profit Margin (Quarterly) | 67.10% |
| Profit Margin (Quarterly) | 12.93% |
| Earnings Yield | 1.46% |
| Operating Earnings Yield | 1.54% |
| Normalized Earnings Yield | 1.457 |